STOCK TITAN
  1. Home
  2. News
  3. B

Barnes Group Inc. - B STOCK NEWS

Welcome to our dedicated page for Barnes Group news (Ticker: B), a resource for investors and traders seeking the latest updates and insights on Barnes Group stock.

Barnes Group Inc. (NYSE: B) is a leading international industrial and aerospace manufacturer and service provider, serving a wide array of markets and customers. The company’s highly engineered products, industrial technologies, and innovative solutions are essential in transportation, manufacturing, healthcare, and technology sectors worldwide.

With approximately 4,700 employees across more than 60 locations on four continents, Barnes Group upholds its long tradition of excellence in precision manufacturing and logistics solutions. The company operates under two main segments: Industrial and Aerospace.

The Industrial segment focuses on manufacturing precision parts and systems for critical applications in transportation, industrial equipment, and consumer products. The Aerospace segment provides machined components and assemblies for OEM turbine engines, airframes, industrial gas turbines, and military applications. Barnes Group’s products are integral to the performance and reliability of these critical systems.

In recent years, Barnes Group has invested significantly in leading-edge technologies to enhance its capabilities and explore breakthrough markets. This forward-thinking approach ensures the company remains at the forefront of innovation, meeting the evolving needs of its diverse customer base.

Barnes Group’s financial health is robust, underscored by strategic partnerships and consistent performance. The company's commitment to sustainable growth and operational excellence is evident in its dedication to quality and customer satisfaction.

For the latest updates and news, stay tuned to Barnes Group Inc.’s announcements and developments, which reflect its dynamic presence in the global market.

News

Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completed

Rhea-AI Summary
Eisai submits sBLA for monthly IV maintenance dosing of Leqembi for Alzheimer's disease treatment. The application is based on Phase 2b and Clarity AD studies data. Fast Track designation sought for SC formulation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.31%
Tags
none
-
News

Lecanemab deliberations at the CHMP regarding the Marketing Authorisation Application in the EU have been rescheduled due to procedural reasons

Rhea-AI Summary
BioArctic AB's partner Eisai faces procedural delays at EMA for lecanemab review, impacting SAG-N meeting. The decision does not affect the Marketing Authorisation Application for lecanemab. BioArctic and Eisai collaborate on lecanemab development, with BioArctic having commercialization rights in the Nordic region.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
none
-
News

Barnes Announces First Quarter 2024 Earnings Conference Call and Webcast

Rhea-AI Summary
Barnes Group Inc. (NYSE: B) is set to announce its first quarter 2024 financial results on April 26, 2024, followed by a conference call to discuss the outcomes and the company's future prospects. Investors and analysts can access the live webcast or join the call directly to gain insights into Barnes Group's performance and outlook.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.9%
Tags
earnings
News

ETQ Expands Real-Time Document Collaboration, Adds Broader Data Collection Features to ETQ Reliance NXG Cloud-Native Quality Management System

Rhea-AI Summary
ETQ, part of Hexagon, introduces new features and functionality in the ETQ Reliance NXG quality management system to enhance flexibility and efficiency for customers in manufacturing sectors. The latest release includes real-time document collaboration with Microsoft 365, expanded data collection capabilities, and user interface enhancements for improved user experience.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
none
-
News

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

Rhea-AI Summary
BioArctic AB and Eisai present new data on lecanemab at the 2024 International Conference on Alzheimer's and Parkinson's Diseases. The data highlights the efficacy and safety of lecanemab in treating Alzheimer's disease, showing promising results in reducing Aβ protofibrils and plaques in the brain. The collaboration between BioArctic and Eisai has been instrumental in the development and regulatory submissions of lecanemab.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.27%
Tags
none
-
News

98% manufacturers face data woes that stifle innovation and time to market, Hexagon's report reveals

Rhea-AI Summary
A new report from Hexagon highlights that manufacturers face significant challenges with data quality and availability, hindering the adoption of advanced technologies like digital twins, automation, and AI. The report reveals that 98% of manufacturers encounter data issues within their organizations, impacting workplace collaboration, productivity, and innovation. Nearly 40% of manufacturers risk falling behind due to lagging automation practices.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
none
News

BioArctic's partner Eisai presents updated sales simulation for Leqembi® at its annual press conference

Rhea-AI Summary
BioArctic AB's partner Eisai projects significant sales growth for Leqembi, an Alzheimer's disease treatment, with sales expected to reach JPY 290 billion in FY2026 and JPY 1.6 trillion in FY2032.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.06%
Tags
none
-
News

Barnes Announces Update to Board of Directors

Rhea-AI Summary
Barnes Group Inc. (B) announces the planned retirements of Chairman Thomas O. Barnes and Lead Independent Director Mylle H. Mangum. Richard Hipple appointed as Chair Elect. Adam Katz joins the Board. Cooperation agreement with Irenic Capital Management. Thomas O. Barnes to become Chairman Emeritus. Board of Directors selects Richard J. Hipple as Chair Elect.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
management
-
News

Crawford & Company Reports 2023 Fourth Quarter and Full Year Results Achieved Record Revenues for Year

Rhea-AI Summary
Crawford & Company (CRD) releases Q4 2023 financial results with a revenue decrease of 8% compared to 2022. GAAP net loss improved to $(0.8) million from $(14.1) million in 2022 Q4. Non-GAAP net income was $3.3 million in 2023 Q4, down from $11.4 million in the previous year. Full year 2023 showed a 7% revenue increase over 2022, with net income of $30.6 million compared to a loss of $(18.3) million in 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
none
News

Integrum AB: Invitation to the Third Quarter 2023/24 Results Presentation

Rhea-AI Summary
Integrum (INTEG) will host a webcast presentation of its third quarter 2023/24 results on February 29, 2024, at 14:00 CEST. CEO Rickard Brånemark, CFO Jörgen Svanström, and US President Jeffrey Zanni will present in English. The report will be available at integrum.se, and the webcast can be accessed at finwire.tv.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
earnings

FAQ

What is the current stock price of Barnes Group (B)?

The current stock price of Barnes Group (B) is $46.82 as of November 22, 2024.

What is the market cap of Barnes Group (B)?

The market cap of Barnes Group (B) is approximately 2.4B.

What does Barnes Group Inc. specialize in?

Barnes Group Inc. specializes in manufacturing highly engineered products and providing industrial technologies and innovative solutions across transportation, manufacturing, healthcare, and technology sectors.

How is Barnes Group Inc. structured?

Barnes Group Inc. operates under two main segments: Industrial, which focuses on precision parts for transportation and industrial applications, and Aerospace, which provides components and assemblies for turbine engines and airframes.

Where are Barnes Group Inc.'s operations located?

Barnes Group Inc. operates in more than 60 locations worldwide, spanning four continents.

How many employees does Barnes Group Inc. have?

Barnes Group Inc. employs approximately 4,700 dedicated professionals.

What are the key markets served by Barnes Group Inc.?

Barnes Group Inc. serves key markets including transportation, industrial equipment, consumer products, and aerospace.

What are some recent achievements of Barnes Group Inc.?

Barnes Group Inc. has made significant investments in leading-edge technologies and breakthrough markets, enhancing its capabilities and maintaining its leadership in precision manufacturing and logistics solutions.

What makes Barnes Group Inc. products unique?

Barnes Group Inc.'s products are highly engineered and critical to the performance and reliability of systems in transportation, industrial equipment, and aerospace applications.

How does Barnes Group Inc. ensure quality and customer satisfaction?

Barnes Group Inc. is committed to sustainable growth, operational excellence, and continuous investment in technology to meet and exceed customer expectations.

Who are the typical customers of Barnes Group Inc.?

Barnes Group Inc. serves a wide range of customers in sectors such as transportation, industrial equipment, medical and personal care, mobility, and packaging.

What are the future plans of Barnes Group Inc.?

Barnes Group Inc. aims to continue building on its tradition of excellence in precision manufacturing and expand into new markets through continuous innovation and strategic investments.

Stock B logo
Barnes Group Inc.

Nasdaq:B

B Rankings

#1873 Ranked by Market Cap
#1611 Ranked by Dividends

B Stock Data

2.38B
46.22M
9.17%
93.7%
1.44%
Specialty Industrial Machinery
Miscellaneous Fabricated Metal Products
Link
United States of America
BRISTOL